Comparative Pharmacology
Head-to-head clinical analysis: COLOVAGE versus PEG 3350 AND ELECTROLYTES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLOVAGE versus PEG 3350 AND ELECTROLYTES.
COLOVAGE vs PEG 3350 AND ELECTROLYTES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COLOVAGE is a bowel cleansing preparation containing polyethylene glycol 3350 and electrolytes. It acts as an osmotic laxative, causing fluid retention in the colon to stimulate bowel evacuation.
PEG 3350 is an osmotic laxative that retains water in the bowel lumen via hydrogen bonding, increasing fecal water content and stimulating peristalsis. Electrolytes (sodium sulfate, potassium chloride, sodium bicarbonate, magnesium sulfate) prevent significant fluid and electrolyte shifts by maintaining isotonicity.
4 liters of PEG-3350 electrolyte solution orally as a single dose for colon cleansing prior to colonoscopy; alternatively, 2 liters with ascorbic acid regimen.
4 liters orally of the reconstituted solution administered as a single dose at 240 mL every 10 minutes or 1 to 1.5 L/hour until rectal effluent is clear. Alternatively, 240 mL every 10 minutes until 4 L consumed.
None Documented
None Documented
Not applicable (non-absorbed, gut lavage); systemic absorption minimal
Not applicable; PEG 3350 undergoes minimal systemic absorption (<0.2%), thus no meaningful terminal half-life. Systemic half-life of absorbed fraction is <2 hours.
Primarily fecal as unabsorbed drug; negligible renal excretion (<5%)
Primarily fecal (96–98%) as unabsorbed PEG 3350; electrolytes absorbed are excreted renally (sodium, potassium) and via feces (biliary excretion negligible).
Category C
Category C
Osmotic Laxative
Osmotic Laxative